Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06521047

A Multicentre Observational Study to Assess Long-term Outcome of Participants in the EXCELLENT Clinical Trial

Status
Recruiting
Phase
Study type
Observational
Enrollment
48 (estimated)
Sponsor
CellProthera · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The PERFECT study is an observational study designed to follow patients randomised in the EXCELLENT study (NCT02669810) for 10 years. The aim is to assess the long-term clinical outcomes for patients randomised to the Standard of Care arm or the ProtheraCytes arm.

Conditions

Interventions

TypeNameDescription
OTHERNA - Observational studyObservational study, data collection only.

Timeline

Start date
2024-07-20
Primary completion
2034-03-15
Completion
2034-03-15
First posted
2024-07-25
Last updated
2024-09-25

Locations

10 sites across 2 countries: France, United Kingdom

Source: ClinicalTrials.gov record NCT06521047. Inclusion in this directory is not an endorsement.